CurveBeam AI Limited (ASX:CVB)
Australia · Delayed Price · Currency is AUD 0.0320
+0.0070 (28.00%)
At close: Sep 17, 2026
CurveBeam AI Market Cap
CurveBeam AI has a market cap or net worth of 24.56 million as of September 17, 2026. Its market cap has decreased by -50.34% in one year.
Market Cap
24.56M
Enterprise Value
40.57M
Revenue
8.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since August 23, 2023, CurveBeam AI's market cap has decreased from 108.85M to 24.56M, a decrease of -77.44%. That is a compound annual growth rate of -38.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 24.56M | -29.06% |
| Dec 31, 2025 | 34.62M | -34.20% |
| Dec 31, 2024 | 52.62M | -60.39% |
| Dec 29, 2023 | 132.86M | 22.06% |
| Aug 23, 2023 | 108.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 45.93M |
| Nova Eye Medical | 38.46M |
| HeraMED | 38.24M |
| OncoSil Medical | 34.19M |
| Control Bionics | 33.13M |
| CleanSpace Holdings | 29.36M |
| Memphasys | 18.52M |
| ImpediMed | 18.31M |